Xinmin Cao

5.4k citations
45 papers · 4.7k indexed · 1 hit paper · h-index 32

Xinmin Cao

45 papers receiving 4.6k citations

Hit Papers

A zinc finger-encoding gene coregulated with c-fos during...1.2k19882026200020132505007501000

Peers

Xinmin Cao
Comparison fields: 5 of 109
  • Oncology 1.8k
  • Immunology 1.0k
  • Cancer Research 615
  • Molecular Biology 2.8k
  • Cellular and Molecular Neuroscience 518
Replace Hsin‐Fang Yang‐Yen with:
Hsin‐Fang Yang‐Yen Taiwan
Frédéric Hollande Australia
W. Kruijer Netherlands
Margaret Favata United States
Nancy A. Jenkins United States
Kei-ichi Nakayama Japan
David C. Hancock United Kingdom
A. Krust France
Xiaohong Mao China
Tung O. Chan United States
Xinmin Cao relative to Hsin‐Fang Yang‐Yen Taiwan Hsin‐Fang Yang‐Yen's profile →
Citations per field
00.5×1.7×
Hsin‐Fang Yang‐Yen · 1×
Citations per year

Countries citing papers authored by Xinmin Cao

Since Specialization
Citations

This map shows the geographic impact of Xinmin Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinmin Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinmin Cao more than expected).

Fields of papers citing papers by Xinmin Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinmin Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinmin Cao. The network helps show where Xinmin Cao may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xinmin Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xinmin Cao Line = papers co-authored together Xinmin Cao links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 200978
2 200928
3 200874
4 200821
5 200827
6 200875
7 2008138
8 200878
9 200731
10 2006226
11 2006261
12 2005104
13 200528
14 200422
15 200390
16 1998182
17 1998146
18 199650
19 1990104
20 199057

About Xinmin Cao

Xinmin Cao is a scholar working on Oncology, Molecular Biology and Pharmacology, having authored 45 papers that have together received 4.7k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (20 papers), Melanoma and MAPK Pathways (8 papers), Signaling Pathways in Disease (6 papers), interferon and immune responses (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Nuclear Receptors and Signaling (4 papers), NF-κB Signaling Pathways (4 papers) and Mitochondrial Function and Pathology (3 papers). The work is most often cited by research in Oncology (1.8k citations), Immunology (1.0k citations) and Cancer Research (615 citations). Xinmin Cao has collaborated with scholars based in Singapore, United States and China. Frequent co-authors include Cheh Peng Lim, Neeraj Jain, Vikas P. Sukhatme, Tong Zhang, Tom Curran, Donna Cohén, Graeme R. Guy, Thomas B. Shows, Chon‐Hwa Tsai‐Morris and S. Edwards. Their work appears in journals such as Journal of Biological Chemistry, Molecular and Cellular Biology, Oncogene, Biochemical Journal and Molecular Biology of the Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026